NEW YORK, July 23 – Amersham Pharmacia Biotech has acquired Dan-Process, a Danish supplier of protein synthesis and chromatography systems, from Pantax, its parent company, Amersham said Monday.
Financial details were not disclosed.
Dan-Process manufactures equipment for the benchtop and large scale synthesis of polypeptides, including fermentation reactors, and chromatography systems for purifying peptides and peptide hormones.
Peder Dahl, the founder of Dan-Process, will continue to run the day-to-day operations of the company. AP Biotech, of Piscataway, NJ, will sell Dan-Process’ products through its global sales force.
"The acquisition of Dan-Process strengthens our bioprocess portfolio for the purification of peptides and peptide hormones and enhances our ability to offer a complete system solution to our biopharmaceutical customers," Peter Ehrenheim, executive vice president of separations at AP Biotech, said in a statement.AP Biotech filed for an initial public offering last October, but has postponed the transaction because of market conditions.